(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ORICIRO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ORICIRO

ST13

US500000079274176

Class

1, 5, 9, 40, 42

Filing

79274176

Registration

6197550

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

11/18/2025

Trademark type

Combined

Nice classes

1, 5, 9, 40, 42

Filing date

07/23/2019

Registration date

11/17/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/17/2020

Last transaction

11/18/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

03

Owner location

JP

Examiner

STEDMAN, CORI

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a design of a waved circle with five convex parts and five concave parts in blue-grey, interwoven with a waved semicircle with three convex parts and three concave parts in blue to the left of the word "ORICIRO" in black. The color white represents background, outlining, shading, and/or transparent area is not part of the mark.

Holders and representatives

Holders

OriCiro Genomics, Inc.

Representatives

Sandra Epp Ryan Hamre, Schumann, Mueller & Larson, P.C.

Technical classification

Nice Classes

Class 1Class 5Class 9Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical reagents for genetic researchother than for medical or veterinary purposes; chemical reagentsother than for medical or veterinary purposes; reagents for scientific and research usefor DNA amplification; reagents for genetic research purposesother than for medical or veterinary purposes; reagents for research purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; reagents for scientific purposes; chemicals for use in the manufacture of pharmaceuticals; industrial chemicals; test paperchemical; reagent paperother than for medical or veterinary purposes

Class 5

Chemical reagents for medical purposes; diagnostic reagents for medical purposes; reagents for use in medical genetic testing; reagentsfor medical purposes; diagnostic preparations for medical purposes; pharmaceutical preparationsfor the treatment of diseases caused by genetic disorder; reagent paper for medical purposes

Class 9

Genetic specimen samplersother than for medical usetesting sample collection equipment in the nature of wipes and swabs for use in diagnostic testingnot for medical purposes; DNA chips; DNA chip making apparatus being a DNA microarray apparatus; DNA synthesizing apparatusDNA microarray; DNA analyzing apparatuslaboratory research instruments for DNA analysis; scientific apparatus and instruments and laboratory apparatus for research purposespolymerase chain reaction thermocyclers used to amplify DNAfor analytical and research purposes; DNA fragmentation apparatuslaboratory apparatus to separate or for breaking DNA strands into pieces; gene testing equipment for research purposeselectrical equipment for the genetic modification of cells for research purposes; analytical apparatuslaboratory apparatus for extracting DNA for use in laboratory; laboratory kits for use with reagents for DNA amplification comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; laboratory kits for use with reagents for genetic research comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; laboratory apparatus and instruments in the form of kits comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; measuring or testing machines and instrumentsscientific apparatus and instruments for measuring relative DNARNA and protein

Class 40

Custom treatment of materials in the nature of syntheses of DNA; custom treatment of materials in the nature of syntheses of RNA; custom treatment of materials in the nature of syntheses of nucleic acids; custom treatment of materials in the nature of amplification of DNA; custom manufacture of chemicals; processing of chemical reagents; processing of medicinal materialsmedicinal plants; custom manufactureextractionpurification and syntheses of pharmaceuticals; custom manufacture of pharmaceuticals; treatment of biopharmaceutical materials by means of DNA engineering; providing material treatment information

Class 42

Testinginspectionresearch or development services in the fields of genesresearch in the fields of geneticsgene therapyDNA and chemical and biological production methods; consultancy and information services relating to testinginspectionresearch or development services in the fields of genesscientific research consulting in the fields of geneticsgene therapyDNA and chemical and biological production methods; scientific research in the fields of genetics and genetic engineering; testinginspectionresearch or development services in the fields of chemistryscientific research and development in the fields of chemistry; consultancy and information services relating to testinginspectionresearch or development services in the fields of chemistrychemistry consultation; testinginspectionresearch or development services in the fields of pharmaceuticalstestinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy including DNA and RNA-based therapy and vaccines; consultancy and information services relating to testinginspectionresearch or development services in the fields of pharmaceuticalsscientific research consulting in the fields of pharmaceuticals; testinginspection or research on agriculturelivestock breeding or fisheries; testing or research on prevention of pollution; scientific laboratory services

Publications

History of USPTO decisions and trademark events.

27 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

11/17/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/20/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

01/20/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/20/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/20/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/21/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/26/2021

FIMP

FINAL DISPOSITION PROCESSED

02/26/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/17/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/11/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

11/17/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/01/2020

PUBO

PUBLISHED FOR OPPOSITION

09/01/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/12/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/24/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/23/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/22/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/22/2020

RFNT

REFUSAL PROCESSED BY IB

02/08/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/23/2020

RFRR

REFUSAL PROCESSED BY MPU

01/23/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/24/2019

MAFR

APPLICATION FILING RECEIPT MAILED

12/24/2019

CNRT

NON-FINAL ACTION WRITTEN

12/23/2019

DOCK

ASSIGNED TO EXAMINER

12/20/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/20/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/19/2019

Continuous trademark protection

Get notified about every new filing that threatens ORICIRO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.